Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma

Overview of attention for article published in Frontiers in Pharmacology, July 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,179 followers.

Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma: Introduction: The effect of the conventional treatment methods of glioblastoma (GBM) is poor and the prognosis of patients is poor. The expression of MCL-1 in…

04 Aug 2023

Reply Repost Favourite

New Research: Development of an MCL-1-related prognostic signature and inhibitors screening for glioblastoma #pharmacology https://t.co/LH6QEBCTjj

19 Jul 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.